Early tumor cells employ subtle immune evasion strategies for survival, such as downregulating major histocompatibility complex (MHC) expression to present less immunogenic antigens while maintaining sufficient surface MHC levels to evade clearance by NK cells (43). Here, HLA-C is linked to neoplasm.